✦ LIBER ✦

Treatment of obstetric hemorrhage with recombinant activated factor VII (rFVIIa)

✍ Scribed by S. Segal; I. Y. Shemesh; R. Blumenthal; B. Yoffe; N. Laufer; Y. Ezra; I. Levy; M. Mazor; U. Martinowitz

Publisher: Springer
Year: 2002
Tongue: English
Weight: 113 KB
Volume: 268
Category: Article
ISSN: 0003-9128
DOI: 10.1007/s00404-002-0409-1

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Recombinant activated factor VII (rFVIIa

Recombinant activated factor VII (rFVIIa) therapy for intracranial hemorrhage in hemophilia a patients with inhibitors

✍ M. L. Schmidt; S. Gamerman; H. E. Smith; J. P. Scott; D. M. DiMichele 📂 Article 📅 1994 🏛 John Wiley and Sons 🌐 English ⚖ 467 KB 👁 2 views

Activated recombinant human coagulation

Activated recombinant human coagulation factor VII (rFVIIa) therapy for abdominal bleeding in patients with inhibitory antibodies to factor VIII

✍ Liebman, Howard A.; Chediak, Juan; Fink, Kenneth I.; Galvez, Angel G.; Shah, Pra 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 31 KB 👁 2 views

Eight patients with inhibitors to factor VIII (4 hemophilia A and 4 nonhemophilic) were treated with recombinant activated factor VII (rFVIIa) to control severe abdominal bleeding. The recombinant factor was supplied under an open-label, emergency-use program to patients previously unresponsive to o

Postoperative pulmonary thromboembolism

Postoperative pulmonary thromboembolism possibly associated with recombinant activated factor VII infusion for the treatment of uncontrolled hemorrhage during vertebral instrumentation

✍ Zahid Hussain Khan; Alireza Ebrahim Soltani; Payman Rahmani 📂 Article 📅 2007 🏛 Springer 🌐 English ⚖ 110 KB

Use of recombinant activated factor VII

Use of recombinant activated factor VII for treatment of a retropharyngeal hemorrhage in a hemophilic patient with a high titer inhibitor

✍ B. Gail Macik; John Hohneker; H. R. Roberts; Anne M. Griffin 📂 Article 📅 1989 🏛 John Wiley and Sons 🌐 English ⚖ 254 KB 👁 2 views

Succesful management of life-threatening

Succesful management of life-threatening hemorrhage in a patient with osteogenesis imperfecta by low-dose activated recombinant factor VII

✍ Annick Becotte; P. Moliner; G. Devroede; H. Knecht 📂 Article 📅 2008 🏛 Springer-Verlag 🌐 French ⚖ 94 KB

Recombinant activated factor VII (rFVIIa

Recombinant activated factor VII (rFVIIa) as a hemostatic agent in liver disease: A break from convention in need of controlled trials

✍ Stephen H. Caldwell; Charissa Chang; B. Gail Macik 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 256 KB 👁 1 views

The management of coagulopathy in patients with acute and chronic liver disease has undergone little change in many years despite advances in our understanding of the pathogenesis of this problem. In general, deficiency of clotting factors as a result of poor hepatic synthetic function accounts for